Prevalence of Human GH-1 Gene Alterations in Patients with Isolated Growth Hormone Deficiency

被引:0
|
作者
Johann K Wagner
Andrée Eblé
Peter C Hindmarsh
Primus E Mullis
机构
[1] University Children's Hospital,Division of Paediatric Endocrinology
[2] the Cobbold Laboratories,undefined
[3] Middlesex Hospital,undefined
来源
Pediatric Research | 1998年 / 43卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Human GH is encoded by the GH-1 gene which belongs to the GH gene cluster encompassing a distance of about 65 kb on the long arm of chromosome 17. Familial isolated growth hormone deficiency (IGHD) is associated with at least four Mendelian disorders. These include two forms that have autosomal recessive inheritance (IGHD types IA and IB) as well as autosomal dominant(IGHD type II) and X-linked (IGHD III) forms. The aim of our study was to evaluate the prevalence of all GH-1 gene alterations by sequencing the whole GH-1 gene after PCR amplification among 151 affected subjects from 83 families with severe IGHD (height: <-4.5 SD score). A high frequency of GH-1 gene alterations was found in families with IGHD type IA (8/12, 66.7%), whereas only a low frequency of GH-1 gene defects was present in all the other GH-deficient families (7/71, 9.9%). The absolute frequency of GH-1 gene deletions was 8.7% (6/69), 11.8% (4/34), and 18.7% (9/48) in Northern Europeans, Mediterraneans, and Asians, respectively, giving an overall frequency of 12.5% (19/151). The sizes of the deletions were heterogeneous with the most frequent (78%) being 6.7 kb. In addition, 6% (9/151) of the patients presented GH-1 gene mutations such as frameshift, stop codon and splicing error. Furthermore, total GH-1 gene abnormalities varied among different populations from 11.6% in Northern Europe, 14.7% in Mediterranean countries and 31.2% in Asia. Most striking, however, was the low frequency rate of 1.7% (2/119) of GH-1 gene mutations responsible for the most common phenotype of IGHD, namely type IB, among the subjects characterized by the production of deficient but detectable amounts of GH after provocative stimuli. This finding underlines the necessity to focus rather on the promoter region of the GH-1 gene (cis-acting elements and trans-acting factors), and on other candidate genes specific for the GH axis than the GH-1 gene itself to define genetically the IGHD type IB phenotype in more detail.
引用
收藏
页码:105 / 110
页数:5
相关论文
共 50 条
  • [21] A novel and de novo splice-donor site mutation in intron 3 of the GH-1 gene in a patient with isolated growth hormone deficiency
    Katsumata, N
    Matsuo, S
    Sato, N
    Tanaka, T
    GROWTH HORMONE & IGF RESEARCH, 2001, 11 (06) : 378 - 383
  • [22] Growth Hormone (GH) Deficiency Type II: A Novel GH-1 Gene Mutation (GH-R178H) Affecting Secretion and Action
    Petkovic, Vibor
    Godi, Michela
    Pandey, Amit V.
    Lochmatter, Didier
    Buchanan, Charles R.
    Dattani, Mehul T.
    Eble, Andree
    Flueck, Christa E.
    Mullis, Primus E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02): : 731 - 739
  • [23] Reduced human growth hormone (hGH) bioactivity without a defect of the GH-1 gene in three patients with rhGH responsive growth failure
    Binder, G
    Benz, MR
    Elmlinger, M
    Pflaum, CD
    Strasburger, CJ
    Ranke, MB
    CLINICAL ENDOCRINOLOGY, 1999, 51 (01) : 89 - 95
  • [24] Hereditary isolated growth hormone deficiency caused by GH1 gene mutations in Japanese patients
    Kamijo, T
    Hayashi, Y
    Seo, H
    Ogawa, M
    GROWTH HORMONE & IGF RESEARCH, 1999, 9 : 31 - 34
  • [25] ISOLATED GROWTH-HORMONE DEFICIENCY - ANALYSIS OF THE GROWTH-HORMONE (GH)-RELEASING HORMONE GENE AND THE GH GENE-CLUSTER
    MULLIS, P
    PATEL, M
    BRICKELL, PM
    BROOK, CGD
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (01): : 187 - 191
  • [26] PREVALENCE OF HUMAN GROWTH HORMONE-1 GENE DELETIONS AMONG PATIENTS WITH ISOLATED GROWTH-HORMONE DEFICIENCY FROM DIFFERENT POPULATIONS
    MULLIS, PE
    AKINCI, A
    KANAKA, C
    EBLE, A
    BROOK, CGD
    PEDIATRIC RESEARCH, 1992, 31 (05) : 532 - 534
  • [27] Targeting GH-1 splicing as a novel pharmacological strategy for growth hormone deficiency type II
    Miletta, Maria Consolata
    Flueck, Christa E.
    Mullis, Primus-E.
    BIOCHEMICAL PHARMACOLOGY, 2017, 124 : 1 - 9
  • [28] KINETIN IMPAIRS GH-1 SPLICING IN AN IN VITRO MODEL OF GROWTH HORMONE DEFICIENCY TYPE II
    Miletta, Maria Consolata
    Biason-Lauber, Anna
    Bozzola, Mauro
    Fluck, Christa E.
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 123 - 124
  • [29] ISOLATED GROWTH-HORMONE (GH) DEFICIENCY TYPE 1A ASSOCIATED WITH A DOUBLE DELETION IN THE HUMAN GH GENE-CLUSTER
    GOOSSENS, M
    BRAUNER, R
    CZERNICHOW, P
    DUQUESNOY, P
    RAPPAPORT, R
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (04): : 712 - 716
  • [30] Mutations in intron 3 of GH-1 gene associated with isolated GH deficiency type II in three Japanese families
    Kamijo, T
    Hayashi, Y
    Shimatsu, A
    Kinoshita, E
    Yoshimoto, M
    Ogawa, M
    Seo, H
    CLINICAL ENDOCRINOLOGY, 1999, 51 (03) : 355 - 360